TELA Bio Inc. (TELA)
TELA Bio Statistics
Share Statistics
TELA Bio has 39.55M shares outstanding. The number of shares has increased by 60.42% in one year.
| Shares Outstanding | 39.55M |
| Shares Change (YoY) | 60.42% |
| Shares Change (QoQ) | 0.41% |
| Owned by Institutions (%) | 99.99% |
| Shares Floating | 31.78M |
| Failed to Deliver (FTD) Shares | 400 |
| FTD / Avg. Volume | 0.16% |
Short Selling Information
The latest short interest is 351.56K, so 0.89% of the outstanding shares have been sold short.
| Short Interest | 351.56K |
| Short % of Shares Out | 0.89% |
| Short % of Float | 1.14% |
| Short Ratio (days to cover) | 1.97 |
Valuation Ratios
The PE ratio is -2.28 and the forward PE ratio is -4.21. TELA Bio's PEG ratio is 0.07.
| PE Ratio | -2.28 |
| Forward PE | -4.21 |
| PS Ratio | 1.24 |
| Forward PS | 0.3 |
| PB Ratio | 3.03 |
| P/FCF Ratio | -2.02 |
| PEG Ratio | 0.07 |
Enterprise Valuation
Currently the Enterprise Value (EV) is not available for TELA Bio.
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 5.01, with a Debt / Equity ratio of 1.46.
| Current Ratio | 5.01 |
| Quick Ratio | 4.19 |
| Debt / Equity | 1.46 |
| Debt / EBITDA | -1.32 |
| Debt / FCF | -0.98 |
| Interest Coverage | -6.45 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
| Return on Equity | n/a |
| Return on Assets | n/a |
| Return on Invested Capital | n/a |
| Revenue Per Employee | $331.58K |
| Profits Per Employee | $-181.06K |
| Employee Count | 209 |
| Asset Turnover | 0.8 |
| Inventory Turnover | 1.78 |
Taxes
| Income Tax | -144K |
| Effective Tax Rate | 0.38% |
Stock Price Statistics
The stock price has increased by -77.61% in the last 52 weeks. The beta is 0.98, so TELA Bio's price volatility has been higher than the market average.
| Beta | 0.98 |
| 52-Week Price Change | -77.61% |
| 50-Day Moving Average | 2.3 |
| 200-Day Moving Average | 3.03 |
| Relative Strength Index (RSI) | 21.62 |
| Average Volume (20 Days) | 255.92K |
Income Statement
In the last 12 months, TELA Bio had revenue of 69.3M and earned -37.84M in profits. Earnings per share was -1.33.
| Revenue | 69.3M |
| Gross Profit | 46.49M |
| Operating Income | -34.12M |
| Net Income | -37.84M |
| EBITDA | -31.68M |
| EBIT | -32.7M |
| Earnings Per Share (EPS) | -1.33 |
Balance Sheet
The company has 52.67M in cash and 41.67M in debt, giving a net cash position of 11M.
| Cash & Cash Equivalents | 52.67M |
| Total Debt | 41.67M |
| Net Cash | 11M |
| Retained Earnings | -358.73M |
| Total Assets | 86.57M |
| Working Capital | 62.47M |
Cash Flow
In the last 12 months, operating cash flow was -41.59M and capital expenditures -989K, giving a free cash flow of -42.58M.
| Operating Cash Flow | -41.59M |
| Capital Expenditures | -989K |
| Free Cash Flow | -42.58M |
| FCF Per Share | -1.49 |
Margins
Gross margin is 67.08%, with operating and profit margins of -49.23% and -54.6%.
| Gross Margin | 67.08% |
| Operating Margin | -49.23% |
| Pretax Margin | -54.81% |
| Profit Margin | -54.6% |
| EBITDA Margin | -45.72% |
| EBIT Margin | -49.23% |
| FCF Margin | -61.45% |
Dividends & Yields
TELA does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | n/a |
| FCF Yield | n/a |
Analyst Forecast
The average price target for TELA is $7, which is 493.2% higher than the current price. The consensus rating is "Buy".
| Price Target | $7 |
| Price Target Difference | 493.2% |
| Analyst Consensus | Buy |
| Analyst Count | 5 |
Scores
| Altman Z-Score | -4.88 |
| Piotroski F-Score | 2 |